FACE.S-4-KIDS: Deep phenotyping database for childhood craniofacial differences
Official title: FACE.S-4-KIDS : FACE and SKULL for Key Innovative Data Science. Une Base de données de phénotypage Profond Des Anomalies Craniofaciales au Cours du développement
Run by Imagine Institute · NCT07422454 · Data updated 2026-11-12
This project will build a detailed clinical, imaging, photographic, and genetic database to see if combining these data helps doctors better diagnose and plan care for children with craniofacial anomalies.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3100 (estimated) |
| Sponsor | Imagine Institute Academic / other |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | October 16, 2025 |
| Main results expected | October 31, 2031 |
| Study ends | October 31, 2033 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07422454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children with diagnosed craniofacial conditions such as FGFR-related craniosynostosis, achondroplasia/hypochondroplasia, osteogenesis imperfecta, or Pierre Robin sequence who have undergone craniofacial imaging (CT or MRI) and consent to sample/data storage.
✕Probably not a fit
Patients without the listed craniofacial conditions, those who have not had craniofacial imaging or who do not consent to data/sample storage, and individuals unable to attend the single study site are unlikely to benefit directly from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
FACE.S-4-KIDS collects standardized clinical records, high-resolution imaging (CT/MRI), facial photographs, genomic data, and biological samples from well-characterized pediatric patients with craniofacial anomalies and matched controls at a single center. The project organizes these multimodal data into a unified database and runs four pilot projects to explore genotype–phenotype relationships and developmental variability. By integrating surgical, medical, imaging, and laboratory expertise on site, the effort aims to enable consistent, multimodal assessments and longitudinal tracking. The database will support future research on diagnosis, prognosis, and personalized treatment planning.
Why it matters
Potential benefit: If successful, the database could lead to more accurate diagnoses, better prognostic information, and more individualized treatment plans for children with craniofacial anomalies.
How similar studies have gone: Prior registries and genotype–phenotype studies in craniofacial genetics have produced useful diagnostic and research insights, but a single-site, multimodal deep phenotyping database linking imaging, photos, genomics, and longitudinal clinical data is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for patients: 1. Patients suffering from one of the following pathologies: craniostenosis linked to FGFR signaling, achondroplasia / hypochondroplasia, osteogenesis imperfecta, Pierre Robin sequence (with or without anatomical markers). 2. Patients who may or may not have benefited from genome sequencing as part of their care and who (or holders of parental authority where applicable) have consented to the conservation of the remains of their biological samples in one of these collections: * Chondroplasia and craniostenosis, * Constitutional Bone Diseases, * Developmental anomalies. 3. Patients who have undergone craniofacial imaging (CT or MRI) as part of their care. Inclusion Criteria for controls: 1. Patients who have consulted the Genetics, Pediatrics or Maxillofacial Surgery Departments at Necker, with none of these pathologies: FGFR-related craniosynostoses Chondroplasia / hypochondroplasia Osteogenesis imperfecta Pierre Robin sequence (with or without anatomical marker) 2. Patients who have benefited from genome sequencing as part of their care and who have (or holders of parental authority where applicable) consented to the conservation of the remains of their biological samples in the "Infectious Diseases" collection . 3. Patients who have undergone craniofacial imaging (CT or MRI) as part of their treatment. Non-inclusion Criteria: Opposition of the patient or his parents to the reuse of their data from care in this study
Where it's running
-
Pr Stanislas Lyonnet
Paris, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postoperative breathing problems after (adeno)tonsillectomy in children with sleep apnea
See how common breathing problems are after (adeno)tonsillectomy in children with obstructive sleep apnea and which factors raise the risk.
-
Socio‑professional inclusion for young people (15–25) with childhood-onset rare genetic disabilities
This project will try to see what makes it hard for 15–25‑year‑olds with childhood-onset rare genetic conditions to access higher education, internships, or work.
-
Natural history of type I interferonopathies in a European patient group
This project will follow people with genetically confirmed type I interferonopathies across European centers to see how the disease develops and which clinical and blood markers track disease activity.
-
Research on therapeutic targets for nephronophthisis and related kidney diseases
This study is trying to find new treatment options for nephronophthisis and related kidney diseases by testing if existing drugs can fix problems in cells affected by this genetic condition.
-
Understanding Developmental and Epileptic Encephalopathy through Clinical Data
This study is trying to gather and analyze health information from patients with Developmental and Epileptic Encephalopathy to better understand the condition and improve treatment options.
-
Characterizing genetic diseases affecting the immune and neurological systems
This study is trying to learn more about rare genetic diseases that affect the immune and nervous systems to help find better ways to diagnose and treat them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.